Recipharm’s International Environmental Award is presented annually for the best environmental performance or environmental innovation within the pharmaceutical industry or the academic world. Since Recipharm was founded in 1995, our environmental work has played a central part in the way we do business. Indeed, the company has been certified according to ISO 14001 standards since 1997. The award justification:
“The Wellcome Trust Genome Campus continually demonstrates its environmental commitment in ensuring that its environmental impact is minimised, it has taken a holistic approach to this by involving all employees within the organisation.
The achievement of ISO14001 verifies that a systematic and successful environmental management system has been implemented. The numerous environmental initiatives in place have demonstrated a social responsibility and prove that the organisation has a sustainable strategy for the future.”
Commenting on the award, Lars Backsell, Chairman of Recipharm, said: “The Wellcome Trust Sanger Institute’s commitment to the environment provides a shining example of how the biotechnology and pharmaceutical industry can balance success with a social responsibility”.
About Recipharm
Recipharm AB is a leading contract development and manufacturing organisation based in Sweden with 2,000 employees. The company operates 12 development and manufacturing facilities in Sweden, France, the UK, Spain and Germany and is headquartered near Stockholm. Recipharm supplies the global pharmaceuticals market with hundreds of different products in most dosage forms, including solid dose, granulates, powders, sterile liquids and lyophilisates, semisolids, beta-lactams, hormones, and inhalers. www.recipharm.com
Contact
Tristan Jervis or Alex Heeley, De Facto Communications t.jervis@defacto.com or a.heeley@defacto.com tel +44 207 861 3019/3043
